TY - JOUR T1 - Mantle cell lymphoma with involvement of the digestive tract JO - Revista de Gastroenterología de México T2 - AU - Oña-Ortiz,F.M. AU - Sánchez-del Monte,J. AU - Ramírez-Solís,M.E. AU - de la Mora-Levy,J.G. AU - Alonso-Larraga,J.O. AU - Lino-Silva,L.S. AU - Herrera-Servín,M.A. AU - Jiménez-Morales,M. AU - Manzano-Robleda,M.C. AU - Yañez-Cruz,M. AU - Hernández-Guerrero,A.I. SN - 2255534X M3 - 10.1016/j.rgmxen.2018.11.003 DO - 10.1016/j.rgmxen.2018.11.003 UR - http://revistagastroenterologiamexico.org/en-mantle-cell-lymphoma-with-involvement-articulo-S2255534X18301476 AB - Introduction and aimMantle cell lymphoma is an aggressive subtype of B-cell non-Hodgkin lymphoma and its incidence is 0.5/100,000 inhabitants. Gastrointestinal involvement at diagnosis is 15-30%. The aim of our study was to analyze the clinical and endoscopic characteristics of mantle cell lymphoma affecting the digestive tract. Material and methodsA retrospective study was conducted, based on a case series of patients with mantle cell lymphoma affecting the gastrointestinal tract that were diagnosed over a 10-year period. ResultsTen patients (11.7%) had gastrointestinal tract involvement. The upper endoscopic findings were polypoid lesions (66%), thickened folds (44%), and nonspecific changes in the mucosa (33%). At colonoscopy, polypoid lesions were viewed in 100% of the patients and ulcerated lesions in 40%. ConclusionPolypoid lesions are the most common endoscopic characteristics in patients with mantle cell lymphoma of the gastrointestinal tract. Upper endoscopy and colonoscopy should be carried out on patients with mantle cell lymphoma, even those with nonspecific symptoms, to check their gastrointestinal status. Gastrointestinal involvement has an impact on disease staging. ER -